Project Grant R01DK149540
Award Date 8/13/26
Completion Date 3/31/30
Dollars Obligated $715K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Richmond, VA 23298, USA
Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Pittsburgh $148,155 on August 17, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support a five-year project examining the role of PIEZO1, a mechanosensitive cation channel, in renal function and fibrosis. The research investigates PIEZO1 regulation and activity in the distal nephron through two primary aims. Aim 1 examines how aldosterone and...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Virginia $702,191 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct basic biomedical research on cell volume regulatory mechanisms and their role in autonomous aldosterone production. The research targets primary aldosteronism, a genetic condition characterized by excessive aldosterone production independent of the...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Virginia $797,878 on February 24, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate the pathogenesis of concentric hypertrophy of kidney arterioles. The research examines how chronic stimulation of renin cells—triggered by renin-angiotensin system inhibitors or genetic mutations—leads to concentric arterial and arteriolar hypertrophy, a...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Duke University $1,636,543 on March 17, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate the role of the ubiquitin editor A20 in regulating sodium transport and the hypertensive response through selective actions in kidney epithelial cells and tubules. The research addresses the mechanisms through which A20 suppresses inflammatory cytokines that modulate...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Emory University $821,916 on March 20, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate mechanisms of angiotensin II signaling within kidney intercalated cells. The research examines how angiotensin II upregulates pendrin, a chloride-bicarbonate exchanger expressed on intercalated cells that modulates acid-base balance and blood pressure regulation. The...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded $121,125 to the University of Virginia on May 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to engineer and optimize a three-dimensional microfluidic co-culture system that models the gut-on-chip and investigates how biomechanical forces—specifically stretch and stiffness—affect enteric neurons and glia. The project addresses chronic idiopathic constipation and...
- The National Institute of Diabetes and Digestive and Kidney Diseases, a component of the Department of Health and Human Services, awarded Virginia Commonwealth University $421,744 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate the regulation of liver regeneration by hepatocyte-derived extracellular vesicles. The project will characterize the role of microRNAs carried by hepatocyte-derived extracellular vesicles...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Beth Israel Deaconess Medical Center $1.552 million on September 9, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to map mechanosensory circuits from the bladder to Barrington's nucleus. The recipient will use immediate early gene activity, RNA sequencing, fiber photometry, and cellular-resolution calcium imaging to identify central nervous system nuclei and cell...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Rush University Medical Center $749,087 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate sodium-independent mechanisms of edema in nephrotic syndrome. The project studies the role of circulating angiopoietin-like 4 (ANGPTL4), specifically its C-fragment, as a mediator of skin capillary endothelial permeability in nephrotic...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Arkansas for Medical Sciences $717,457 on February 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate metabolic rewiring of T cells and the pathogenic connection between diabetes and hypertension. The research examines immune-metabolic crosstalk in the progression from type 2 diabetes to hypertension using a high-fat diet-induced...